{"title":"更正“AQX-1125，小分子SHIP1激活剂抑制博莱霉素诱导的肺纤维化”。","authors":"","doi":"10.1111/bph.17416","DOIUrl":null,"url":null,"abstract":"<p>\n <span>J. Cross</span>, <span>G. R. Stenton</span>, <span>C. Harwig</span>, <span>C. Szabo</span>, <span>T. Genovese</span>, <span>R. Di Paola</span>, <span>E. Esposito</span>, <span>S. Cuzzocrea</span>, and <span>L. F. Mackenzie</span>, “ <span>AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis</span>,” <i>British Journal of Pharmacology</i> <span>174</span>, no. <span>18</span> (<span>2017</span>): <span>3045</span>–<span>3057</span>, https://doi.org/10.1111/bph.13934</p><p>In the published version of the article, duplication has been detected between the “30 mg•kg<sup>−1</sup>” panel in Figure 1A and the “Sham” panel in Figure 1B. In the corrected Figure 1A, below, the “30 mg•kg<sup>−1</sup>” panel has been replaced with the correct one.</p><p>The authors confirm that all the experimental results and corresponding conclusions mentioned in the paper remain unaffected.</p><p>The authors apologize for the mistake and for the inconvenience caused.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":"182 3","pages":"924"},"PeriodicalIF":6.8000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bph.17416","citationCount":"0","resultStr":"{\"title\":\"Correction to “AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis”\",\"authors\":\"\",\"doi\":\"10.1111/bph.17416\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>\\n <span>J. Cross</span>, <span>G. R. Stenton</span>, <span>C. Harwig</span>, <span>C. Szabo</span>, <span>T. Genovese</span>, <span>R. Di Paola</span>, <span>E. Esposito</span>, <span>S. Cuzzocrea</span>, and <span>L. F. Mackenzie</span>, “ <span>AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis</span>,” <i>British Journal of Pharmacology</i> <span>174</span>, no. <span>18</span> (<span>2017</span>): <span>3045</span>–<span>3057</span>, https://doi.org/10.1111/bph.13934</p><p>In the published version of the article, duplication has been detected between the “30 mg•kg<sup>−1</sup>” panel in Figure 1A and the “Sham” panel in Figure 1B. In the corrected Figure 1A, below, the “30 mg•kg<sup>−1</sup>” panel has been replaced with the correct one.</p><p>The authors confirm that all the experimental results and corresponding conclusions mentioned in the paper remain unaffected.</p><p>The authors apologize for the mistake and for the inconvenience caused.</p>\",\"PeriodicalId\":9262,\"journal\":{\"name\":\"British Journal of Pharmacology\",\"volume\":\"182 3\",\"pages\":\"924\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2024-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bph.17416\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bph.17416\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bph.17416","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Correction to “AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis”
J. Cross, G. R. Stenton, C. Harwig, C. Szabo, T. Genovese, R. Di Paola, E. Esposito, S. Cuzzocrea, and L. F. Mackenzie, “ AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis,” British Journal of Pharmacology174, no. 18 (2017): 3045–3057, https://doi.org/10.1111/bph.13934
In the published version of the article, duplication has been detected between the “30 mg•kg−1” panel in Figure 1A and the “Sham” panel in Figure 1B. In the corrected Figure 1A, below, the “30 mg•kg−1” panel has been replaced with the correct one.
The authors confirm that all the experimental results and corresponding conclusions mentioned in the paper remain unaffected.
The authors apologize for the mistake and for the inconvenience caused.
期刊介绍：
The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries.
Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues.
In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
